Literature DB >> 11453454

High mitochondrial DNA T8993G mutation (<90%) without typical features of Leigh's and NARP syndromes.

C Y Tsao1, J R Mendell, D Bartholomew.   

Abstract

Neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome and maternally inherited Leigh's syndrome have been associated with T8993G point mutations in the mitochondrial adenosine triphosphatase 6 gene. Typically, NARP syndrome is characterized by developmental delay, seizures, dementia, retinitis pigmentosa, ataxia, sensory neuropathy, and proximal weakness. Usually, there is a correlation between the percentage of mutated mitochondrial DNA and clinical severity, and when mutated mitochondrial DNA is > 90%, it is often seen with Leigh's syndrome. We now report a family with mitochondrial DNA T8993G mutation in eight living members, five with mutant mitochondrial DNA >90% and one with 20% mutant mitochondrial DNA. However, their clinical features include variable combinations of seizures, behavior problems, learning disability, mental retardation, sensorineural deafness, cerebellar ataxia, and proximal muscle weakness. No retinitis pigmentosa was found in all eight living members, including a 56-year-old grandmother. Only one dead female relative was diagnosed with Leigh's syndrome on the neuropathologic examination at age 22 years, when she died of an accident. High mitochondrial DNA T8993G mutation is not always associated with typical features of Leigh's and NARP syndromes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453454     DOI: 10.1177/088307380101600716

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

Review 1.  Modeling mitochondrial encephalomyopathy in Drosophila.

Authors:  Michael J Palladino
Journal:  Neurobiol Dis       Date:  2010-05-21       Impact factor: 5.996

Review 2.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

3.  Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells.

Authors:  M D'Aurelio; C Vives-Bauza; M M Davidson; G Manfredi
Journal:  Hum Mol Genet       Date:  2009-10-29       Impact factor: 6.150

4.  Intractable Epilepsy in Maternally Inherited Leigh Syndrome (MILS) Due to the Sporadic Variant m.8993T>G in MT-ATP6: A Case Report.

Authors:  Josef Finsterer
Journal:  Cureus       Date:  2022-02-28

5.  Adaptive optics scanning laser ophthalmoscopy images in a family with the mitochondrial DNA T8993C mutation.

Authors:  Michael K Yoon; Austin Roorda; Yuhua Zhang; Chiaki Nakanishi; Lee-Jun C Wong; Qing Zhang; Leslie Gillum; Ari Green; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-07       Impact factor: 4.799

6.  Role of dynamic and mitochondrial mutations in neurodegenerative diseases with ataxia: lower repeats and LNAs at multiple loci as alternative pathogenesis.

Authors:  Waseem Gul Lone; Subhadra Poornima; Angmuthu Kanikannan Meena; Kaipa Prabhakar Rao; Qurratulain Hasan
Journal:  J Mol Neurosci       Date:  2014-10-12       Impact factor: 3.444

7.  Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease.

Authors:  S R Bacman; S L Williams; D Duan; C T Moraes
Journal:  Gene Ther       Date:  2011-12-01       Impact factor: 5.250

8.  Effects of Tributyltin Chloride on Cybrids with or without an ATP Synthase Pathologic Mutation.

Authors:  Ester López-Gallardo; Laura Llobet; Sonia Emperador; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Environ Health Perspect       Date:  2016-04-29       Impact factor: 9.031

9.  Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations.

Authors:  Gerald Pfeffer; Emma L Blakely; Charlotte L Alston; Adam Hassani; Mike Boggild; Rita Horvath; David C Samuels; Robert W Taylor; Patrick F Chinnery
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-05-10       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.